Home

Phillip Gross

CIK 1403413 · last filed 2017-09-28

Phillip Gross is a corporate insider who has filed 26 SEC Form 4 insider transactions across 8 companies since 2009. The most recent filing shows the insider sold $45.0M of CALA on Sep 28, 2017. Across all open-market trades the lifetime net is +$7.0M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $33.1M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$33.07M

Companies

8

Total Filings

26

Lifetime Open-Market Net

$7.01M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Calithera Biosciences, Inc. (CALA) Delisted 10%+ Owner 179,244 $0.00 $54 -$7.82M 5 2017-09-28
PBYI 10%+ Owner 3,854,302 $8.58 $33.07M -$39.33M 3 2017-06-12
MULESOFT, INC (MULE) Delisted 10%+ Owner 675,000 — — -$3.13M 1 2017-03-21
Ayala Pharmaceuticals, Inc. (ADXS.W) Delisted 10%+ Owner 5,917,766 — — $21.23M 1 2015-08-24
HeartWare International, Inc. (HTWR) Delisted 10%+ Owner 1,875,316 — — -$69.91M 1 2015-04-21
AMAG PHARMACEUTICALS, INC. (AMAG) Delisted 10%+ Owner 3,796,592 — — $143.60M 8 2013-09-26
Sleep Number Corp (SCSS) Delisted 10%+ Owner 6,792,200 — — -$51.78M 3 2011-02-03
BOULDER BRANDS, INC. (SMBL) Delisted 10%+ Owner 7,343,302 — — $14.15M 1 2009-03-26

Recent Filings

26 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2017-09-28 Calithera Biosciences, Inc. (CALA) Delisted Sell (S) −2,880,000 -$45.04M EDGAR
2017-06-12 PBYI Sell (S) −1,236,300 -$99.29M EDGAR
2017-03-24 Calithera Biosciences, Inc. (CALA) Delisted Buy (P) +2,439,020 $25.00M EDGAR
2017-03-21 MULESOFT, INC (MULE) Delisted Sell (S) −125,000 -$3.13M EDGAR
2016-04-07 — Sell (S) −24,110,635 -$2.49M
2015-09-24 Calithera Biosciences, Inc. (CALA) Delisted Buy (P) +534,840 $3.22M EDGAR
2015-09-08 Calithera Biosciences, Inc. (CALA) Delisted Buy (P) +451,500 $2.68M EDGAR
2015-08-24 Ayala Pharmaceuticals, Inc. (ADXS.W) Delisted Buy (P) +1,500,000 $21.23M EDGAR
2015-04-21 HeartWare International, Inc. (HTWR) Delisted Sell (S) −866,335 -$69.91M EDGAR
2014-10-15 Calithera Biosciences, Inc. (CALA) Delisted Buy (P) +908,500 $6.32M EDGAR
Showing 1–10 of 26
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.